Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Junior researcher makes Kovsies proud
2014-11-11

Herkulaas Combrink received the Junior Researcher Award at the 3rd Annual Health Research Day held on 30 and 31 October 2014. On this day, clinicians and scientists shared information on research that will impact health in the Free State.

Combrink is a student in the Faculty of Health Sciences’ Department of Human Genetics, as well as Medical Science intern with the Health Professions Council of South Africa (HPCSA). His research project: ‘Familial Breast Cancer in BRCA1 and BRCA2 within the Indian population of South Africa’ forms part of an umbrella study which looks at the various populations of South Africa for familial breast cancer mutations within BRCA1 and BRCA2 genes, so that diagnostic panels can be created. This is the first study of its kind to be done on this population group in South Africa.

He says: “I am passionate about my research and the impact of my work. I am hard-working and believe in the value of my contribution to science. My philosophy is that theory must always be put into practice. I apply this philosophy to everything I pursue.”

The research week was held by the School of Medicine in conjunction with the Free State Department of Health.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept